India’s Deal Street Revs Up Targeting Brands, Medical Devices, Contract Manufacturing
This article was originally published in PharmAsia News
Executive Summary
While the overall Indian pharmaceutical market is seeing early signs of a rebound after a dull 2013, interest is steadily building for buyout targets like high yield brands, medical devices and companies that bring expertise to manufacturing.